Viva Biotech Holdings Free Cash Flow Generation Index

Latest as of June 2023: 1.32x

Viva Biotech Holdings free cash flow generation index. Viva Biotech Holdings (VB0) has a Free Cash Flow Generation Index of 1.32x as of June 2023. Free cash flow of €209.53 Million represents 1% of operating cash flow (€158.72 Million).

FCF Generation Index

1.32x
Free Cash Flow / Operating CF

Free Cash Flow

€209.53 Million
EUR

Operating Cash Flow

€158.72 Million
EUR

Capital Expenditures

€50.80 Million
EUR

Free Cash Flow Generation Index of Viva Biotech Holdings (2016–2024)

Free cash flow generation index of Viva Biotech Holdings from 2016 to 2024. Historical FCF Generation Index trend for Viva Biotech Holdings across 9 annual periods. See VB0 FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.

Viva Biotech Holdings Free Cash Flow Generation Index by Year (2016–2024)

Viva Biotech Holdings free cash flow generation index by year from 2016 to 2024. Year-by-year Free Cash Flow Generation Index for Viva Biotech Holdings. For the full cash flow conversion analysis, see cash flow conversion of Viva Biotech Holdings.

Year FCG Index Free Cash Flow (EUR) Operating CF Capital Expenditures YoY Change
2024 0.49x €182.32 Million €373.99 Million €191.67 Million ▼ -4.4%
2023 0.51x €195.57 Million €383.40 Million €187.84 Million ▲ +44.3%
2022 0.35x €136.51 Million €386.05 Million €249.33 Million ▲ +105.6%
2021 -6.28x €-488.49 Million €77.83 Million €565.18 Million ▲ +53.7%
2020 -13.56x €-585.70 Million €43.18 Million €592.62 Million ▼ -3846.2%
2019 -0.34x €-15.81 Million €46.01 Million €56.19 Million ▲ +88.0%
2018 -2.87x €-34.79 Million €12.11 Million €46.90 Million ▼ -993.5%
2017 0.32x €8.97 Million €27.89 Million €18.92 Million ▼ -76.1%
2016 1.35x €28.46 Million €21.12 Million €7.34 Million —
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).